Reimbursement

Commonwealth Fund authors call for a deeper policy look into a system that limits options for beneficiaries without their knowledge.

Humana disputed the findings and raised concerns about HHS' methodology, saying it’s "inconsistent with statistical principles."

The signees view the lack of a second application period as a hindrance to the move toward value-based care.

Revenues, profit and earnings per share all saw increases both month-over-month and year-over-year.

The pandemic has acted as an accelerant for the development and evolution of these technologies.

President Biden is expected to sign the bill into law.

The impact of the payment policies would result in an increase of about $444 million in Medicare Part A payments in 2022.

CMS is also proposing to add Consumer Assessment of Healthcare Providers and Systems Hospice Survey Star ratings on Care Compare.

This week's top stories include U.S. Anesthesia Partners claiming UnitedHealthcare has an "unlawful scheme" to eliminate providers like itself from its network, Bright Health buying Zipnosis, and AstraZeneca working with MGH on disease management.

With specialty reintegrated into the pharmacy services, the goal is to deliver cost savings for Service Benefit Plan members.